UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043128
Receipt number R000049222
Scientific Title Safety study of fetoscopic diagnosis and therapy for lower urinary tract obstruction (LUTO)
Date of disclosure of the study information 2021/01/25
Last modified on 2024/11/23 08:42:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety study of fetoscopic diagnosis and therapy for lower urinary tract obstruction (LUTO)

Acronym

Safety study of fetoscopic diagnosis and therapy for lower urinary tract obstruction (LUTO)

Scientific Title

Safety study of fetoscopic diagnosis and therapy for lower urinary tract obstruction (LUTO)

Scientific Title:Acronym

Safety study of fetoscopic diagnosis and therapy for lower urinary tract obstruction (LUTO)

Region

Japan


Condition

Condition

Fetal lower urinary tract obstruction

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess feasibility and safety of fetoscopic diagnosis and therapy for lower urinary tract obstruction.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1. The rates of completing fetoscopic diagnosis for lower urinary tract obstruction without severe adverse events of pregnant women
2. The rates of completing fetoscopic therapy for post urethral valve

Key secondary outcomes

1. The rate of agreement between prenatal diagnosis by fetoscopy and postnatal diagnosis
2. The rate of miscarriage and preterm delivery within 48 hours after fetoscopy
3. The rate of fetal demise within 48 hours after fetoscopy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Fetal diagnosis for lower urinary tract obstruction and fetal therapy for post urethral valve using fetoscopy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

For pregnant women
1. Between 16+0 weeks gestation and 25+6 weeks gestation
2. Singleton pregnancy
2. No severe complication
3. No rupture of membrane
4. Cervical length is above 25mm
5. Consent of a pregnant woman and her partner
For fetus
1. Severe lower urinary tract obstruction (megacystis)
2. beta-2 microglobulin is lower than reference value (calculated by the formula: 13.45-0.493*[gestational weeks]+2.6*2) by urine examination
3. Reaccumulation after fetal bladder centesis

Key exclusion criteria

For regnant women
1. Infectious diseases required treatments
2. Positive results of HIV antibody, HCV antibody or HBe antigen
3. Severe psychological disorder
4. American Society of Anesthesiology (ASA) Physical Status Classification Class 3, 4, 5 or 6
5. Multiple pregnancy
6. Severe obesity (BMI >35)
For fetus
1. Unilateral or bilateral cystic change of kidney by ultrasound
2. Severe associated anomaly

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Seiji
Middle name
Last name Wada

Organization

National Center for Child Health and Development

Division name

Division of Fetal Medicine

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535, Japan

TEL

0334160181

Email

wada-s@ncchd.go.jp


Public contact

Name of contact person

1st name Seiji
Middle name
Last name Wada

Organization

National Center for Child Health and Development

Division name

Division of Fetal Medicine

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535, Japan

TEL

0334160181

Homepage URL

https://fetusjapan.jp/clinical/clinical-3135

Email

wada-s@ncchd.go.jp


Sponsor or person

Institute

Division of Fetal Medicine, National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Obstetrics, Osaka Women's and Children's Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee in National Center for Child Health and Development

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535, Japan

Tel

0334160181

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立成育医療研究センター(東京都)、大阪母子医療センター(大阪府)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 03 Day

Date of IRB

2020 Year 04 Month 22 Day

Anticipated trial start date

2021 Year 01 Month 25 Day

Last follow-up date

2027 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 25 Day

Last modified on

2024 Year 11 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049222